Halozyme Therap Drug Patent Portfolio

Halozyme Therap owns 1 orange book drug protected by 1 US patent Given below is the list of Halozyme Therap's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US7767429 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof 23 Sep, 2027
Active


Given below is the list of recent legal activities going on the following drug patents of Halozyme Therap.

Activity Date Patent Number
Patent litigations
Payment of Maintenance Fee, 12th Year, Large Entity 01 Dec, 2021 US7767429 (Litigated)
Payment of Maintenance Fee, 8th Year, Large Entity 08 Jan, 2018 US7767429 (Litigated)
Change in Power of Attorney (May Include Associate POA) 04 Apr, 2011 US7767429 (Litigated)
Correspondence Address Change 30 Mar, 2011 US7767429 (Litigated)
Sequence Moved to Public Database 09 Aug, 2010 US7767429 (Litigated)
Recordation of Patent Grant Mailed 03 Aug, 2010 US7767429 (Litigated)
Patent Issue Date Used in PTA Calculation 03 Aug, 2010 US7767429 (Litigated)
Issue Notification Mailed 14 Jul, 2010 US7767429 (Litigated)
Printer Rush- No mailing 25 Jun, 2010 US7767429 (Litigated)
Pubs Case Remand to TC 22 Jun, 2010 US7767429 (Litigated)
Dispatch to FDC 07 Jun, 2010 US7767429 (Litigated)
Mail-Record a Petition Decision of Granted for Patent Term Adjustment after Allowance 01 Jun, 2010 US7767429 (Litigated)
Record a Petition Decision of Granted for Patent Term Adjustment after Allowance 01 Jun, 2010 US7767429 (Litigated)
Adjustment of PTA Calculation by PTO 31 May, 2010 US7767429 (Litigated)
Mail Response to 312 Amendment (PTO-271) 11 Mar, 2010 US7767429 (Litigated)


Halozyme Therap's Family Patents


Family Patents



Halozyme Therap Drug List

Given below is the complete list of Halozyme Therap's drugs and the patents protecting them.


1. Hylenex Recombinant

Hylenex Recombinant is protected by 1 patent, which is still active. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US7767429 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof 23 Sep, 2027
(2 years from now)
Active

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Hylenex Recombinant's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Halozyme Therap News

Merck (MSD), a prominent multinational pharmaceutical corporation, has officially submitted a...

22 Nov, 2024

See More